Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Who we help

As the trusted partner to the top 50 global pharmaceutical companies and top 10 contract research organizations, our pharmaceutical data, insights, and analytics are used by businesses operating in all areas of the industry.

Our Specialties

For pharmaceutical companies

Bring game-changing drugs to market more efficiently using our insight and analysis. We’ll help you beat the competition and improve healthcare and patient outcomes.

For contract research organizations

We can help position your organization to win more business and enhance your drug development services. You’ll make better-informed, data-driven decisions while bidding on and implementing clinical trials.

For consultancies

Focus on your clients and expand your business opportunities with Pharma Intelligence. We’ll help you build a complete picture of the fast-changing pharmaceutical market with our insight and expertise.

For marketing agencies

You need to understand and communicate complex information simply and persuasively, often across a variety of channels. We can help with branding, multi-channel communication and more.

For the medtech sector

Your trusted source for industry data, analysis, opinion and news. Access the information you need to inform deal making and business cases for product development and quality control and compliance.

Relevant products

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

Curated by experts
Clinical trial landscape view
Ask-the-Analyst™

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Scrip: industry news and insights

Key benefits:

Follow market developments
Go beyond the news
Hear from news makers

In Vivo

In Vivo Personalised Medicine

18 Sep 2019

With more individualized treatments, such as cell and gene therapies, coming to market every day, In Vivo can keep you up to date on the diversity within clinical R&D, trials, the latest trends and the barriers that still exist within personalised medicine. We’ve pulled together a helpful infographic to summaries these changes.

Topic Personalized Medicine

View infographic
Generics Bulletin

Corporate Strategies of the biggest Generics and Biosimilar players

17 Sep 2019

Understand the latest Corporate Strategies of the biggest Generics and Biosimilar players.

Topic Business strategies

Single report
In Vivo

Personalised Medicine: Treating the individual patient

17 Sep 2019

With more individualized treatments, such as cell and gene therapies, coming to market every day, In Vivo can keep you up to date on the diversity within clinical R&D, trials, the latest trends and the barriers that still exist within personalised medicine. We’ve pulled together information covering the increasing focus of personalized medicine in clinical R&D and the future trends of precision medicine.

Topic Personalized Medicine

Single report
Scrip

Inclisiran’s Safety Data Suggest Game-Changing Potential In PCSK9 Market

By Joseph Haas 11 Sep 2019

The Medicines Co. unveiled Phase III safety data for inclisiran showing safety and tolerability comparable to placebo and efficacy in line with the PCSK9 inhibitor class – which should be the reassurance it needs for the oral agent.

Topic Drug development landscape Drug review

View article
Scrip

Interview: AstraZeneca’s Pangalos on Landmark DAPA-HF Resultsv

By Eleanor Malone 11 Sep 2019

AstraZeneca’s head of R&D spoke to Scrip about the outstanding results for dapagliflozin in heart failure regardless of diabetes status.

Topic Company analysis Diabetes

View article
Scrip

Anima Biotech Lighting The Way In Protein Translation

By Jo Shorthouse 10 Sep 2019

Emerging Company Profile: With a new partner in Eli Lilly, Anima Biotech and its disruptive technology that controls protein translation is starting to make waves as it urges the industry to see the light.

Topic Clinical trials

View article
Biomedtracker

Biomedtracker: Improved Custom Company Portfolio Feature

04 Sep 2019

Discover how creating custom company portfolios can help you overcome your toughest business challenges.

Topic Business strategies

Single report
Meddevicetracker

Meddevicetracker: New Company Portfolio Feature

04 Sep 2019

Meddevicetracker now gives you to the ability to find and follow partners or competitors and track their key activities. Quickly and easily identify new partners and keep tabs on your competition with the portfolio feature in Meddevicetracker.

Topic Business strategies Company analysis

Single report
Generics Bulletin

Executive and market moves interviews for exclusive insider knowledge

04 Sep 2019

Get in the side track on the Generics market with executive and market-moves interviews for exclusive insider knowledge.

Topic Business strategies

Single report
Datamonitor Healthcare

Reimbursement and Payer Management of Immune Checkpoint Inhibitors

03 Sep 2019

As immune checkpoint inhibitors continue to gain approvals in expanded patient populations, payers express concern surrounding the potential budget impact of the drug class. Considering the high costs of these treatments in comparison to standard chemotherapy, HTA and reimbursement agencies stress the requirement for solid survival data and highlight that price will be a major factor during negotiations

Topic Drug review

Single report
Citeline

QIDP: What have we GAINed?

By Jonathan Slater 02 Sep 2019

The Generating Antibiotic Incentives Now (GAIN) Act passed into law on July 9, 2012. Seven years on, we review the drugs that have obtained QIDP status, the companies involved, and the clinical trial landscape.

Topic Drug development landscape Drug review

Single report
In Vivo

Six of the Greatest Therapeutic R&D Challenges

23 Aug 2019

Explore the six biggest therapeutic R&D challenges facing the industry today with a free infographic from In Vivo. This snapshot view of the major issues facing R&D is packed with data and insights about everything from drug resistance to diagnostics challenges.

Topic Drug development landscape

View infographic
Medtech Insight

Compliance Corner: 2 FDA Compliance Branch Heads Talk Regulatory Meetings – And What You Can Expect

By Shawn M. Schmitt 23 Aug 2019

US FDA Compliance Branch directors Gina Brackett and Melissa Michurski shed light on the agency's use of regulatory meetings. The FDA has been pulling enforcement punches in recent years, relying more on holding the face-to-face meetings than sending warning letters.

Topic Policy and regulation

View article
Medtech Insight

Updates On The European Commission’s Medtech Agenda And Deadlines For The Rest Of 2019

By Amanda Maxwell 23 Aug 2019

The European Commission updates its rolling plan on progress with key document and structures toward implementation of the new medtech regulations every few months. What is new and what is still to come this year?

View article
In Vivo

In Vivo Content - Relied Upon by Senior Decision Makers

21 Aug 2019

There are many ways to market your brand and establish your business as a thought leader - but none of these methods compare to the distinct advantage gained through marketing with In Vivo and Informa Pharma Intelligence. The articles, news and interviews we feature are used daily by senior decision-makers to support their decisions, and to keep abreast of what their competitors are doing.

Topic Business strategies Medtech

Single report

Latest headlines

Scrip

20 Sep 2019

Pipeline Watch: Phase II Starts In Hearing Loss, Type 1 Diabetes

Link
Scrip

20 Sep 2019

Gene Profiling Identifies Drugs For Childhood Cancers But Access A Problem

Link
Pink Sheet

20 Sep 2019

Longer Medicine Supply Delays Expected In No-Deal Brexit

Link
Pink Sheet

20 Sep 2019

Recent And Upcoming FDA Advisory Committee Meetings

Link
Medtech Insight

20 Sep 2019

Device Week, 20 September, 2019 – Medtech Giants Sign Major Diabetes Partnerships

Link
Scrip

20 Sep 2019

Emmaus Fumes After EMA Rejects Sickle Cell Drug Again

Link
Medtech Insight

20 Sep 2019

Brexit and UK Procurement: Be Ready For Day One

Link
In Vivo

20 Sep 2019

C-Suite Snippets: A Fresh View From Old Science

Link
Medtech Insight

20 Sep 2019

QUOTED. 20 September 2019. Eran Atlas.

Link
Scrip

20 Sep 2019

Brighter News For Varlitinib As Results In Tough Cancer Type Encourage ASLAN

Link
Pink Sheet

19 Sep 2019

Keep It Simple: EU Consults On Future Design Of EMA’s Fee System

Link
Pink Sheet

19 Sep 2019

Rare Disease Cures Accelerator Expected To Drive Lots Of Development – Eventually

Link
Pink Sheet

19 Sep 2019

Clinical Outcome Assessments To Be Developed Under US FDA Grants

Link
Pink Sheet

19 Sep 2019

Industry Still Awaiting Clarity On Brexit Supply Chain Arrangements

Link
Pink Sheet

19 Sep 2019

Part D Out-Of-Pocket Cap Would Be $2,000 In House Drug Pricing Bill

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Who we help

Our Specialties

For pharmaceutical companies

For contract research organizations

For consultancies

For marketing agencies

For the medtech sector

Relevant products

Below are the Product Brand List

Trialtrove: gold standard clinical trials intelligence

Datamonitor Healthcare: data analysis and insight

Scrip: industry news and insights

Pharma Intelligence latest insights

Latest headlines

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store